1. Home
  2. SNSE vs MARPS Comparison

SNSE vs MARPS Comparison

Compare SNSE & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • MARPS
  • Stock Information
  • Founded
  • SNSE 2005
  • MARPS 1956
  • Country
  • SNSE United States
  • MARPS United States
  • Employees
  • SNSE N/A
  • MARPS N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • MARPS Oil & Gas Production
  • Sector
  • SNSE Health Care
  • MARPS Energy
  • Exchange
  • SNSE Nasdaq
  • MARPS Nasdaq
  • Market Cap
  • SNSE 9.3M
  • MARPS 7.8M
  • IPO Year
  • SNSE 2021
  • MARPS N/A
  • Fundamental
  • Price
  • SNSE $0.38
  • MARPS $3.90
  • Analyst Decision
  • SNSE Strong Buy
  • MARPS
  • Analyst Count
  • SNSE 4
  • MARPS 0
  • Target Price
  • SNSE $4.25
  • MARPS N/A
  • AVG Volume (30 Days)
  • SNSE 8.3M
  • MARPS 3.6K
  • Earning Date
  • SNSE 05-08-2025
  • MARPS 01-01-0001
  • Dividend Yield
  • SNSE N/A
  • MARPS 8.47%
  • EPS Growth
  • SNSE N/A
  • MARPS N/A
  • EPS
  • SNSE N/A
  • MARPS 0.30
  • Revenue
  • SNSE N/A
  • MARPS $945,496.00
  • Revenue This Year
  • SNSE N/A
  • MARPS N/A
  • Revenue Next Year
  • SNSE N/A
  • MARPS N/A
  • P/E Ratio
  • SNSE N/A
  • MARPS $12.99
  • Revenue Growth
  • SNSE N/A
  • MARPS N/A
  • 52 Week Low
  • SNSE $0.25
  • MARPS $3.76
  • 52 Week High
  • SNSE $1.94
  • MARPS $5.20
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 48.32
  • MARPS 50.83
  • Support Level
  • SNSE $0.33
  • MARPS $3.85
  • Resistance Level
  • SNSE $0.39
  • MARPS $3.92
  • Average True Range (ATR)
  • SNSE 0.05
  • MARPS 0.06
  • MACD
  • SNSE 0.00
  • MARPS 0.00
  • Stochastic Oscillator
  • SNSE 52.68
  • MARPS 71.31

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

Share on Social Networks: